ArticleEndocrinology, diabetes & metabolism case reports2026
Multivessel spontaneous coronary artery dissection in a young woman using cabergoline.
Article in Endocrinology, diabetes & metabolism case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Summary: We present a unique case of multivessel spontaneous coronary artery dissection (SCAD) in a young woman using cabergoline. This woman presented with an acute coronary syndrome (ACS) on a background of cabergoline use for a prolactinoma diagnosed over 20 years ago. Coronary angiogram revealed multivessel coronary artery dissection in the absence of occlusive disease. SCAD is an increasingly recognised cause of acute ACS; however, cabergoline-induced SCAD is exceedingly rare with limited literature to date. We highlight this important clinical entity to physicians, who must have a high index of clinical suspicion of this diagnosis in ACS presentations on a background of cabergoline use. Learning points: We need a high index of clinical suspicion of SCAD in young women with ACS presentations. Cabergoline therapy may be an important risk factor for consideration in those presenting with a possible SCAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.